SSW Webinar - Addiction and Recovery 2022: Where We Have Been Where We Are Going
2023-01-17 10:00 - 13:00 (America/New_York) | Virtual
Live Webinar
Tuesday, January 17
10am-1pm, ET

$60 | 3 CE hours, Clinical
Katherine Glick, MEd, LPC, LCADC, ACS, CMH

This course examines how the field of addiction treatment and recovery has evolved since the development of 12-step recovery spaces in the 1950’s, from societal conceptualizations about addiction to how treatment and evidence-based practices have shaped what we now call clinical addiction treatment. Particular attention will be paid to how paradigms, stigma, and oppressive systems have influenced and shaped addiction and treatment trends. Participants will critically examine the successes and pitfalls of addiction treatment as it stands today, including specific models and systems of recovery and what the field calls “evidence-based practices”. Special attention will be paid to how the fields of neuroscience, epigenetics, and neuropharmacology have informed what we know today about addiction, and what it means for integrative recovery strategies moving forward.

*A link to register with Zoom to get your login information will be emailed the day before the webinar, and again on the morning of the webinar. Please register at least one hour before the webinar starts, so you have time to receive your login.

NJMS Webinar: Electroconvulsive Therapy
2023-01-17 11:00 - 12:00 | Virtual
Instructor: Robert M. Greenberg, MD
Clinical Professor of Psychiatry, Robert Wood Johnson School of Medicine

To Participate In Virtual Grand Rounds:

Join Zoom Meeting
https://rutgers.zoom.us/j/94795837547?pwd=[REDACTED] Wx2OTB0c1o4WEtLcGw1R2ptZz09

Meeting ID: 947 9583 7547
Password: [REDACTED]

NJMS.Rutgers.edu/Psychiatry

CAS Training - Learning Collaborative: 2023 Wellness Planning
2023-01-19 10:30 - 11:30 | Virtual
Ring in 2023 by joining us to create a wellness plan to build and sustain your wellness and self-care practices in the new year. This session will help you to identify the self-care practices you are currently doing well and the strategies you would like to do or do more of in 2023. Join us to explore how to continue to implement wellness self-care practices and organizational resources to strengthen you personally and professionally including our Wellness Virtual Toolbox and resource
Objectives: By the end of the session, participants will be able to:

Identify wellness self-care strengths and activities
Describe what wellness self-care practices to strengthen or improve
Explain the value of creating a wellness self-care plan
Access the Wellness Virtual Toolkit self-care resources
Identify ways organizations can promote a wellness workplace culture
Describe peer support approaches for building and maintaining resilience

Click HERE to register for this session

From Pills to Fentanyl: Understanding the Opioid Crisis Webinar
2023-01-26 11:00 - 12:00 | Virtual
Thursday, January 26, 2023 @ 11am
Register for this free webinar: CLICK HERE

Dr. Lewis Nelson will examine the beginnings of the opioid crisis, as well as the current state of the epidemic and efforts to stem opioid misuse, overdoses and deaths. His presentation will cover the emergence of fentanyl in recent years.

Dr. Lewis Nelson became the inaugural chair of emergency medicine at Rutgers New Jersey Medical School in 2016. He is a board certified physician in emergency medicine, medical toxicology and addiction medicine. Dr. Nelson attended SUNY Health Sciences Center in Brooklyn and performed his residency training at Mt. Sinai School of Medicine. He previously served as the director of the fellowship in medical toxicology at New York University’s School of Medicine and as vice-chair for academic affairs in the department of emergency medicine.

SSW Webinar: Harm Reduction: From Principles to Practice
2023-02-08 09:30 - 12:30 | Virtual
This interactive webinar will discuss all aspects of harm reduction. Participants will be able to identify at least 3 principles of harm reduction work. Participants will be able to define harm reduction. Participants will also be able to differentiate between a successful harm reduction approach and less successful approaches and identify at least two reasons behind unsuccessful approaches. Participants will be introduced into the diagnostic criteria of the DSM and dimensional criteria of the ASAM 3, in the lens of determining the need of admission to treatment and continued care need from a harm reduction treatment perspective. Participants will be able to identify three different medicated assisted treatments (MAT), and discussion of medicinal marijuana being added as an MAT option.
Instructor: Glenn Duncan, LPC, LCADC, CCS, ACS
Date: Wednesday, February 8, 2023Time: 9:30 am – 12:30 pm ETLocation: Zoom (Interactive Webinar)
Online Live Webinar, Online, NJ

For more information and registration: Click here

SSW Webinar: Ethical and Legal Issues in Substance Abuse Counseling
2023-02-09 09:30 - 12:30 | Virtual
This interactive webinar focuses on the major elements of legal issues surrounding counselors in working with patients who have substance use disorders. In this webinar, participants will learn about the different areas of legal concern for today’s counselors working with clients who have both mental health and substance use issues. Legal areas include scope of clinical practice regarding supervision (including 2019 changes and proposed rule changes), ADC telehealth and telemedicine regulations (proposed in 2021), and NJ Uniform Enforcement Act changes (including 2021 changes). Other recent changes to include the required 3 hours of Legal Standards training include regulation/statute changes in ADC continuing education (3 hours of Legal Standards) and statutory requirements of 1 hour of opioid training (for those dually licensed professionals).
Instructor: Glenn Duncan, LPC, LCADC, CCS, ACS
Date: Thursday, February 9, 2023Time: 9:30 am – 12:30 pm ETLocation: Zoom (Interactive Webinar)
Online Live Webinar, Online, NJ

For more information and registration: Click here

GSAPP Webinar - Alcohol Moderation and Harm Reduction: A Clinician’s Toolbox for Office-Based Practitioners
2023-02-10 09:00 - 12:30 | Virtual
Live Webinar
Date: Friday February 10, 2023
Time: 9am- 12:15pm ET
Instructor: Arnold Washton, PhD
Instructional Level: Intermediate
Participants attending this skills-training workshop will come away with an extensive toolbox of evidence-based alcohol moderation and harm reduction strategies they can apply immediately in clinical practice. Research shows that most people who drink “too much” are not alcoholics and that many of these “problem drinkers” can learn to moderate their drinking within safer limits rather than quit drinking completely. An alternative to traditional abstinence-only approaches, harm reduction supports individualized treatment goals including less risky/harmful drinking, moderate drinking, and abstinence. Any steps taken to reduce negative consequences associated with substance use are viewed as steps in the right direction, whether or not abstinence is the immediate or ultimate goal.
Participants of this workshop will learn how to help clients take a closer look at their alcohol use, set realistic goals, change their drinking patterns, and acquire a better understanding of the role and meaning of alcohol use in their lives. The presentation will include lecture material highlighted by numerous case examples.
3 CE credits for Psychologists (APA)
3 CE credits for New York Psychologists (NYSED)

SSW Webinar: Medical and Legal Marijuana in NJ: Practice and Policy Issues
2023-02-10 09:30 - 12:30 | Virtual
The goal of this interactive webinar is to identify the changes that have occurred in the NJ Medical Marijuana Program. The history of marijuana legalization and major events that have shaped this history are discussed. Known scientific research on the benefits of medical marijuana and the risks associated with marijuana usage are covered, as well as the continued barriers to better scientific research on this topic. Interactive exercises are incorporated in order to have participants analyze child custody issues for clients who are on the NJ medical marijuana program. Other exercises include the participants discussing how treatment is impacted by medical marijuana and participants will analyze under what conditions there would be a “duty to report” a coworker on medical marijuana.

Instructor:
Glenn Duncan, LPC, LCADC, CCS, ACS

Date:
Friday, February 10, 2023

Time:
9:30 am – 12:30 pm ET

Location:
Zoom (Interactive Webinar)

For more information and registration: Click here

Family Medicine and Community Health Grand Rounds - Medical Marijuana
2023-02-14 08:00 - 09:00 | Hybrid Event
The Department of Family Medicine and Community Health’s Grand Rounds on “Medical Marijuana”
Tuesday, Feb. 14 from 8 – 9 a.m.
Presenter: Zeeshan Khan, MD, FAAFP, CMD, Assistant Professor, Rutgers Robert Wood Johnson Medical School
Hybrid format: in person at 303 George Street, Sixth Floor, New Brunswick, and via Zoom.

SSW Webinar: Understanding Tech Dependence in the Context of Current Life Stressors
2023-02-15 09:30 - 15:00 | Virtual
This timely webinar examines the convergence and impact of technology and stress in the midst of Covid-19. Learn how today’s technology inhibits learning, creates attention issues, negatively impacts your health and sets you and your loved ones up for potential unwanted consequences. Discover research showing how technology potential primes individuals for dependence and even violence. Observe how effortlessly pornography is accessed by children, tools that facilitate it and just how predators can easily access children. Learn vital information revealing the conditions ripe for increased psychological imbalance, self injury and even suicide. Get answers to your personal and professional questions. *This is a full day webinar. Attendees must attend the full day to receive a certificate of completion.

Instructor:
John Kriger, MSM, LCADC, CPS

Date:
Wednesday, February 15, 2023

Time:
9:30 am – 3:00 pm ET

Location:
Zoom (Interactive Webinar)
Online Live Webinar, Online, NJ

For more information and registration: Click here

CMBN Colloquium Series: New Approaches to the Neuroscience of Human Drug Addiction: Drug Bias, Natural Language Processing and the Synchronized Brain
2023-02-15 11:00 - 12:00 | Aidekman Research Center, Room 103, 197 University Avenue, Newark, NJ, 07102, United States
Online | Zoom: https://rutgers.zoom.us/j/98443527746?pwd=[REDACTED]
Drug addiction is a chronically relapsing disorder characterized by excessive drug use despite catastrophic personal consequences (e.g., loss of family, job, health) and even when the substance is no longer perceived as pleasurable. In a theoretical model called iRISA (Impaired Response Inhibition and Salience Attribution) we postulated that core impairments in addiction are the disproportionate value/salience attributed to the drug and drug cues at the expense of other reinforcers, with a concomitant decrease in inhibitory control and self-regulation. This model assigns a primary role to the prefrontal cortex, part of the dopaminergic mesocorticolimbic circuit, in these higher-order executive deficits. In this talk, I will present results of human neuroimaging studies where we utilized a multimodal approach (neuropsychology, functional magnetic resonance imaging, diffusion weighted imaging, event-related potentials recordings) across drugs of abuse (cocaine, heroin) to explore the neurobiology underlying these core behavioral, cognitive, emotional and motivational impairments in drug addiction (encompassing drug cue reactivity, impulsivity) as associated with its clinical symptomatology (encompassing craving and drug seeking). Novel results shed light on brain recovery with abstinence and active treatment, inclusive of cognitive enhancement with pharmacological (methylphenidate) and behavioral (cognitive reappraisal) tools, as well as with mindfulness and direct brain stimulation (with transcranial devices). Natural language processing and naturalistic stimuli (i.e., movies: real-life, dynamic, complex and context-rich) are now also being explored in the lab for their use in unraveling ecologically valid brain-behavior biomarkers (and predictors) of both impairment and recovery in drug addiction. Together, this talk will exemplify the use of neuroimaging to better understand human drug addiction and for the development of empirically-based effective neurorehabilitation strategies in this devastating disorder.

GSE Webinar: Writing Grant Proposals
2023-02-16 13:00 - 14:30 | Virtual
The Samuel DeWitt Proctor Institute for Leadership, Equity and Justice is once again hosting its Making Scholarship Public (MSP) series. This virtual series offers best practices on making scholarship more accessible to the public. Each session is focused on a different method to extend the reach of your research. All webinar workshops are free to attend.
Writing Grant Proposals
Thurs., February 16, 2023 | 1:00 – 2:30 PM ET
This interactive session will discuss successful grant-writing strategies, and tools for effectively identifying funding opportunities that align with your goals and research interests.
Read our Quick Guide to Grant Writing for more information about how to write a grant.
Register here!

SSW Webinar: Medications for Opioid Use Disorder (MOUD): Considerations for Effective Interdisciplinary Care
2023-02-23 09:30 - 12:30 | Virtual
In this webinar, participants will increase familiarity with medications used in treatment of Opioid Use Disorders (MOUD), learn how to create a supportive environment for clients, and discuss the evidence and available resources for MOUD.

Instructor:
Bernard Showers, DSW, LCSW

Date:
Thursday, February 23, 2023

Time:
9:30 am – 12:30 pm ET

Location:
Zoom (Interactive Webinar)
Online Live Webinar, Online, NJ

For more information and registration: Click here

DOH Discussion: Crystal Meth Use in Marginalized Communities
2023-03-02 00:00 - 13:30 | Virtual
Registration: Click here

Crystal meth use is a public health concern affecting multiple communities throughout New York State (NYS). For many years, crystal meth has had a devastating impact within marginalized communities. The stigma, shame, and misinformation associated with crystal meth use serve as barriers for those that deserve accurate information, supportive resources, and treatment services.
The AIDS Institute (AI) has received many suggestions from the community to guide and inform response efforts to address crystal meth use in populations such as Black Men who have Sex with Men (MSM), rural communities, and upstate regions. Additionally, in Nov. 2021, the AI held a community listening session to discuss stimulant drug use within the Black MSM community.
Based on the information provided by community stakeholders, education and awareness have been identified as two priority areas. In Feb. 2023, the AI’s Office of Drug User Health (ODUH) launched a community wide initiative: Crystal Meth Use in Marginalized Communities: Discussion Series.
Objective:
This discussion series will hold space for education and awareness through intentional discussions that reflect the impact crystal meth use has in communities that often experience societal and political marginalization, such as Black MSM, the Transgender and Gender Nonconforming (TGNC) community, and groups with lower socio-economic status. Each discussion will feature subject matter experts, individuals with lived experience, service providers and community stakeholders as various themes, such as stigma, sexual health, treatment, miseducation, and more, are explored.
Through these discussions, the AI will gain further insight into the impact of crystal meth use. The AI is committed to utilizing this information and the AI is committed to improving the quality of life for all New Yorkers who use drugs through the promotion of harm reduction practices, and by providing accessible health care and supportive services.
Crystal Meth Discussion flier

RU-WINS Lecture: Dr. Yeka Aponte, NIDA - "Hypothalamic cell types and circuits that drive survival behaviors"
2023-03-03 12:00 - 13:00 | Virtual
Rutgers University Women in Neuroscience (RUWINS) Lecture
Friday, March 3rd, from 12-1pm
“Hypothalamic cell types and circuits that drive survival behaviors”
Dr Yeka Aponte, Senior Investigator at the National Institute on Drug Abuse, The National Institutes of Health
Via zoom (registration link here) – Dr Aponte will be presenting over zoom
In person: Keck Center Conference Room at Nelson Biology Labs, Busch Campus, Piscataway.
Students/postdocs/techs – The talk will be followed by a lunch from 1-2pm (only for trainees) so that folks can get to know the speaker in a smaller group and learn from her at the Keck Center Conference room.

The Aponte lab studies the role of genetically-identified neurons and their projections in behaviors that are essential for survival. Their ultimate goal is to understand how neurons in distinct hypothalamic circuits encode pain and the rewarding and addictive nature of food intake. To answer these questions, they use a combination of optogenetics, chemogenetics, electrophysiology, two- and single-photon fluorescence endomicroscopy, and behavioral assays to manipulate and measure the activity of these genetically-defined neuronal subpopulations in awake behaving mice. Recently, they showed how two of the lateral hypothalamic neuronal populations identified by the expression of the calcium-binding protein parvalbumin (PVALB; LHPV) or leptin receptor (LHLEPR) modulate pain and appetitive behaviors, respectively, in mice. Their work revealed LHPV neurons as regulators of the LH glutamatergic circuitry orchestrating pain behaviors and identified LHLEPR neurons as modulators of a hypothalamic-ventral tegmental midbrain circuit involved in controlling motivation and appetitive behaviors.
Download Flyer – RUWINS March Seminar

NJMS Webinar: Approach to the Challenging Patient on an Inpatient Unit
2023-03-07 11:00 - 12:00 | Virtual
Instructor: Eric Jarmon, MD
Assistant Professor, Department of Psychiatry, Rutgers New Jersey Medical School

To Participate In Virtual Grand Rounds:

Join Zoom Meeting
https://rutgers.zoom.us/j/94795837547?pwd=[REDACTED] Wx2OTB0c1o4WEtLcGw1R2ptZz09

Meeting ID: 947 9583 7547
Password: [REDACTED]

NJMS.Rutgers.edu/Psychiatry

EASS Webinar - Affect, Emotion and Substance Use
2023-03-09 12:30 - 13:30 | Virtual
The Emerging Addiction Science Seminar (EASS) Series
March 9, 2023 12:30 – 1:30pm via Zoom
Affect, Emotion and Substance Use
With Tim Trull, Ph.D.
Register here
Bio: Dr. Timothy Trull, PhD is a Curators’ Distinguished Professor and Byler Distinguished Professor of Psychological Sciences at the University of Missouri department of Psychological Sciences. He is the director of the Personality and Emotion lab. Dr. Trull’s research interests are in the areas of diagnosis and classification of mental disorders, personality disorders, substance use disorders, psychometrics and clinical assessment as well as the relationship between personality and psychopathology, quantitative methods, and ambulatory assessment. Dr. Trull has marked expertise in ambulatory assessment, emotion dysregulation, addictions, and quantitative methods. Additionally, Dr. Trull has published a number of papers on the interface between affect, emotion, substance use, and psychopathology, especially borderline personality disorder and disorders of emotion dysregulation, including depression.

CHI Science Seminar (Hybrid): Neural Basis of Behavioral Variability
2023-03-16 12:00 - 13:00 | Hybrid Event
Child Health Institute of New Jersey Science Seminar
“Neural basis of behavioral variability”
Speaker: Gowan Tervo, PhD
Lab Head, HHMI Janelia Farm Research Campus
Date and Time: Thursday, March 16, 2023 at 12:00 – 1:00 pm (EST)

HYBRID: Conference Room 3209, CHINJ
*Masks are Mandatory*
Via Zoom:
https://rutgers.zoom.us/j/98737273554?pwd=[REDACTED]
Meeting ID: 987 3727 3554 Password: [REDACTED]

NJ ACTS Webinar - Patterns in Geographic Distribution of Substance Use Disorder Treatment Facilities in the US and Accepted Forms of Payment from 2010 to 2021
2023-03-21 12:00 - 13:00 | Virtual
NJ ACTS Special Populations Core 2023 Seminar Series – Patterns in Geographic Distribution of Substance Use Disorder Treatment Facilities in the US and Accepted Forms of Payment from 2010 to 2021
The ongoing drug overdose crisis is a continuing public health problem and is expected to grow substantially in older adults. Using a unique database of specialty providers, Jonathan Cantor and team assess whether the geographic availability of services was limited for older adults despite the increasing need for substance use disorder and opioid use disorder treatments in this population.
Presenter: Dr. Jonathan Cantor is a Full Policy Researcher at the RAND Corporation. His work focuses on the impact of government healthcare programs on substance use disorder and mental health treatment. Jonathan uses theoretical frameworks and research methods from health economics, policy analysis, and public health. He has a doctorate of philosophy in Public Administration from the Robert F. Wagner Graduate School of Public Service at New York University.

Event Zoom link: https://go.rutgers.edu/fq8xve1u

EASS Webinar - Emerging Evidence on Psychedelic-assisted Treatments for Substance Use Disorders
2023-03-23 12:30 - 13:30 | Virtual
The Emerging Addiction Science Seminar (EASS) Series
March 23, 2023 12:30 – 1:30pm via Zoom
Emerging Evidence on Psychedelic-assisted Treatments for Substance Use Disorders

with Albert Garcia-Romeu, Ph.D.
Register here
Description: Growing evidence suggests substantial therapeutic potential of psychedelic-assisted treatments for mental health conditions including mood and substance use disorders. Data from historical and contemporary studies examining psychedelic therapies will be presented along with a discussion of current hypotheses surrounding biological and psychological mechanisms of action relevant to psychedelic-assisted treatments. Important facets of psychedelic therapy models will be described in addition to potential risks and contraindications.
Bio: Albert Garcia-Romeu, Ph.D. is an Assistant Professor of Psychiatry and Behavioral Sciences at the Johns Hopkins University School of Medicine. His research examines the effects of psychedelics in humans, with a focus on psilocybin as an aid in the treatment of addiction. His current research interests include clinical applications of psychedelics, real-world drug use patterns, diversity in science, and the role of spirituality in mental health. He is a founding member of the Johns Hopkins Center for Psychedelic and Consciousness Research and the International Society for Research on Psychedelics. He serves on the Board of Directors for the College on Problems of Drug Dependence (CPDD) and is an Associate Editor for the journal Psychedelic Medicine.

GSE Webinar: Writing Scholarly Books
2023-03-23 13:00 - 14:30 | Virtual
The Samuel DeWitt Proctor Institute for Leadership, Equity and Justice is once again hosting its Making Scholarship Public (MSP) series. This virtual series offers best practices on making scholarship more accessible to the public. Each session is focused on a different method to extend the reach of your research. All webinar workshops are free to attend.
Writing Scholarly Books
Thurs., March 23, 2023 | 1:00 – 2:30 PM ET
In this workshop, participants will learn how to organize and write a scholarly, authored book, dedicate time to writing, craft a book proposal, and navigate the book publishing process.
Register here!

GSAPP Webinar: Opioids Then and Now
2023-03-24 09:30 | Virtual
Date: Friday, March 24, 2023
Time: 9:30am-12:45pm ET
For more information and registration: Click here

Instructor: Ana Guerra, LCSW, LPC, LCADC, CCS
Instructional Level: Introductory

In 2020, nearly 75% of overdose deaths involved an opioid (CDC, 2022). As the rates of Opioid Use Disorders (OUD) have increased, so has the need for a collaborative response to the crisis. This course identifies factors that contributed to the escalation of opioid use and highlights implications for treatment. Participants will review DSM-5 TR diagnostic criteria and learn about the physiological effects of opioids including Neonatal Abstinence Syndrome. Participants will examine the benefits and misconceptions of pharmacotherapy (Medication Assisted Treatment) as well as opioid diversion activities and efforts to combat them. Discussion and activities strive to empower participants to serve as agents of change.

The Partnership for a Drug-Free NJ Learning Series - Alternatives to Opioids
2023-03-30 11:00 - 12:00 | Virtual
This webinar will focus on the many alternatives that can be used instead of opioids for treating pain. Presenters will also touch on recent updates to CDC guidelines for prescribing opioids.
Learning Objectives
At the conclusion of this activity, learners should be better able to:
1. Describe the prescription drug and opioid abuse epidemic in your community
2. Identify pathways for development of addiction in patients exposed to opioids
3. Recommend pharmacologic and other alternatives to opioids for treating pain
4. Work with your care team to address the epidemic of opioid addiction and the rising levels of misuse and abuse and deaths including diversion, harm reduction, and signs and symptoms
FREE Webinar registration: CLICK HERE

National Alcohol Screening Day
2023-04-07

ECHO Series: Buprenorphine Induction in the Age of Fentanyl
2023-04-07 12:30 - 13:00
This ECHO series is focused on best practices and current thinking in a safe space for peer-to-peer learning and open dialogue. Led by medical experts and psychiatrists from the New Jersey Medical School and Rowan Medicine, discussion topics include understanding specific substances, integrating substance use disorder treatment in primary care settings, and medication-assisted approaches.

More information: click here

SSW Webinar: What's Eating You? The Psychology of Eating
2023-04-11 10:00 - 13:00 | Virtual
This webinar focuses on understanding the psychological processes underlying humans development of eating behaviors and the adoption of both healthy and maladaptive cognitions and behaviors concerning food, eating, and our bodies. Issues to be addressed include: food choice, the development of food preferences, motivation to eat, cultural influences on eating patterns, weight-regulation, body image, dieting behaviors, obesity, eating disorders, and the treatment of unhealthy and clinical eating problems. The psychology of eating will be emphasized, and psychological problems associated with eating will be highlighted.

Instructor:
Katherine Glick, LPC, LCADC, CCS, ACS, MAC

Date:
Tuesday, April 11, 2023

Time:
10:00 am – 1:00 pm ET

Location:
Zoom (Interactive Webinar)

SSW Webinar: The Opioid Crisis in NJ: Current Trends and Evidence-Based Treatment Options
2023-04-12 09:30 - 12:30 | Virtual
This interactive webinar will discuss the latest developments and trends regarding natural opiates, semi-synthetic opioids, and synthetic opioids. Participants will be able to identify national and local NJ trends with regards to prescribing practices and new legislation, opioid overdoses and trends with opioid use. Participants will be able to distinguish the difference between which drugs are considered naturally occurring opiates, which are considered semi-synthetic opioids and which are considered synthetic opioids. Participants will be introduced into the assessment of and treatment of Opioid Use Disorders via the DSM 5 criteria, the latest nationally recognized medicated assisted treatment and the non-medication assisted treatment approaches when working with clients. Participants will be able to identify three different medicated assisted treatments (MAT), and discussion of medicinal marijuana being added as an MAT option. Webinar participants will be introduced to a harm reduction treatment paradigm and will be able to identify at least 3 different harm reduction principles when working with clients. Finally, participants will engage in an interactive case that will develop throughout the webinar and have different objectives (e.g., assessing a proper level of care, and then incorporating a harm reduction treatment orientation with the client in regards to their MAT decision process).

Instructor:
Glenn Duncan, LPC, LCADC, CCS, ACS

Date:
Wednesday, April 12, 2023

Time:
9:30 am – 12:30 pm ET

Location:
Zoom (Interactive Webinar)
Online Live Webinar, Online, NJ

For more information and registration: Click here

CCNP Webinar: Active Learning Impairments in Substance Use Disorders when Solving the Explore-Exploit Dilemma: Longitudinal Stability, Symptom Prediction, and Replication
2023-04-12 10:00 - 11:00 | Virtual
CCNP Seminar: Active Learning Impairments in Substance Use Disorders when Solving the Explore-Exploit Dilemma: Longitudinal Stability, Symptom Prediction, and Replication
Ryan Smith
Laureate Institute for Brain Research, University of Tulsa

Active Learning Impairments in Substance Use Disorders when Solving the Explore-Exploit Dilemma: Longitudinal Stability, Symptom Prediction, and Replication
Computational modeling is a promising approach for parsing behavioral processes and dysfunctions in individuals with substance use disorders (SUDs), but it is unclear how much these processes change during the recovery period. In this talk, I will describe a study in which we assessed baseline and 1-year follow-up data on a sample of healthy controls (HCs; N = 48) and treatment-seeking individuals with one or more SUDs (alcohol, cannabis, sedatives, stimulants, hallucinogens, and/or opioids; N = 83) who completed a standard ‘three-armed bandit’ task designed to assess explore-exploit behavior. I will also describe a pre-registered replication study with a new sample of 168 individuals with SUDs and 99 HCs. Computational models – based on the notion of active learning – were fit to behavior on the task. Relative to HCs, participants with SUDs were found at baseline to show slower learning rates in response to negative outcomes and less precise action selection. We then repeated these analyses when the same individuals returned and re-performed the task 1 year later to assess the stability of these baseline differences. We also examined whether baseline modelling measures could predict symptoms at follow-up. Bayesian analyses indicated that: (a) group differences in learning rates were stable over time (posterior probability = 1); (b) relationships between model parameters at baseline and follow-up were all significant and ranged from small to moderate (.25 < ICCs < .54); and (c) learning rates and/or information-seeking values at baseline were associated with substance use severity at 1-year follow-up in stimulant and opioid users (.36 < rs < .43, .002 < ps < .02). Differences in learning rates for losses replicated in the second sample, and model parameters could jointly differentiate specific substance disorders when combining samples. These findings suggest that processing dysfunctions involving learning to arbitrate between exploration and exploitation may show some stability throughout the recovery period. At the same time, individual computational differences at baseline had some predictive value for changes in substance use severity. Taken together, these results suggest active learning models may allow measurement of trait dysfunctions that could have predictive utility for substance use severity.

Location/Logistics

Wednesday, April 12th, 10-11am EST
Zoom link: https://princeton.zoom.us/j/6397147065

FYI, abstracts for previous talks are posted on the CCNP website: ccnp.princeton.edu. A list of upcoming seminars, job announcements, and other info about CCNP are available there as well.

GSAPP Center for Psychological Services - RU Ready to Quit Smoking Support Meeting
2023-04-12 18:00 - 19:00
RU Ready to quit smoking? GSAPP’s Center for Psychological Services (CPS) is here to offer support to all students, faculty, and staff. Join their meeting on Wed., April 12th at 6:00PM; it is completely cost-and judgement-free!
To register: https://buff.ly/43fEhZB

RWJMS Psychiatry Grand Rounds: Buprenorphine Dosing and Risk of Diversion in NJ DOC
2023-04-13 09:00 - 10:30 | UBHC Building, 671 Hoes Ln. W., Piscataway, NJ, 08854, United States
PSYCHIATRY GRAND ROUNDS
Provided by Rutgers Robert Wood Johnson Medical School
Department of Psychiatry
Thursday, March April 13, 2023
9:00 – 10:30 a.m.
LIVE – Hybrid Event
Please join us in Room D203 at UBHC or via zoom.
Light refreshments provided
https://rutgers.zoom.us/j/95200522015?pwd=[REDACTED]
Meeting ID 928 2215 3006: Password 389511

Clinical and Legal Implications of Biomarkers for Mild Traumatic Brain Injury

William McBride, DO
Forensic Fellow
Buprenorphine Dosing and Risk of Diversion in NJ DOC

Tracy Martin, MD
Forensic Fellow
Donald (Rusty) Reeves, Md
Director of Psychiatry, Rutgers – University Correctional Health Care
Professor, Department of Psychiatry, Rutgers – Robert Wood Johnson Medical School
Forensic Psychiatry Training Director, Rutgers – Robert Wood Johnson Medical School
Anthony Tamburello, MD, CCHP
UCHC Statewide Associate Director of Psychiatry
Clinical Associate Professor, Rutgers–Robert Wood Johnson Medical School
